These data are confirmed also in vivo mouse tumour models suggesting that HOTAIR targets the ATG2B inhibitor miR-130a to upregulate the level of cell autophagy thereby promoting the imatinib resistance in GISTs (J. Zhang et al., 2021a). The gene discussed is HOTAIR; the disease is neoplasm.